Cost-Effectiveness of More Intensive Blood Pressure Treatment in Patients with High Risk of Cardiovascular Disease in Saudi Arabia: A Modelling Study of Meta-Analysis

Table 2

Projected health outcomes, costs, and QALY of more intensive vs. less intensive BP strategy.

Outcomes	Less intensive strategy	More intensive strategy	Incremental
Clinical outcomes in 30 years (per 10,000 patients)
Total number of CV deaths	1,333	1,191	−142
Total number of strokes	1,968	1,227	−341
Total number of MI	1,485	1,244	−241
Total number of HF	873	724	−149
Total	5,559	4,686	−873
Health effects in 30 years (QALYs)
Total QALYs	103,644	109,408	5,764
Total QALYs (undiscounted)	127,939	136,248	8,309
Mean QALYs	10.36	10.94	0.58
Costs ($)
Total costs	481,862,925	599,205,821	117,342,896
Total costs (undiscounted)	590,522,950	743,973,695	153,450,745
Mean cost (per patient per year)	48,186	59,920	11,734
Incremental cost-effectiveness results in 30 years ($/QALY gained)
ICER	—	—	20,358
ICER (undiscounted)	—	—	18,467
ICER in 5 years	—	—	44,562
ICER in 10 years	—	—	30,111
ICER in 20 years	—	—	22,425